ResearcherShanghai Jiao Tong UniversityNo recent work listed
Ming Zhan
Matched on ORCID iD 0000-0002-4668-727X; OpenAlex author ID A5028221595. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 3, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 6
- The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. Last author DOI 10.1016/j.ebiom.2020.103195↗
- miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. Co-author DOI 10.1080/15384101.2020.1831254↗
- Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients. First author DOI 10.1080/15384101.2018.1520558↗
- miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis. First author DOI 10.1038/cddis.2017.530↗
- miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. First author DOI 10.1186/s12943-017-0723-7↗
- Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis. Co-author DOI 10.2147/ott.s95744↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ruimeng Yang · 5 shared papers, 2017–2021 · strength 0.47
- Paper The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. DOI 10.1016/j.ebiom.2020.103195↗
- Paper miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. DOI 10.1080/15384101.2020.1831254↗
- Paper Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients. DOI 10.1080/15384101.2018.1520558↗
- Linhua Yang · 3 shared papers, 2017–2021 · strength 0.31
- Paper The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. DOI 10.1016/j.ebiom.2020.103195↗
- Paper miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. DOI 10.1080/15384101.2020.1831254↗
- Paper miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EM… DOI 10.1038/cddis.2017.530↗
- Jian Wang · 4 shared papers, 2016–2018 · strength 0.30
- Paper Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients. DOI 10.1080/15384101.2018.1520558↗
- Paper Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis. DOI 10.2147/ott.s95744↗
- Paper miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EM… DOI 10.1038/cddis.2017.530↗
- Manmei Long · 3 shared papers, 2017–2020 · strength 0.24
- Paper miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. DOI 10.1080/15384101.2020.1831254↗
- Paper miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EM… DOI 10.1038/cddis.2017.530↗
- Paper miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. DOI 10.1186/s12943-017-0723-7↗
- Qiang Liu · 2 shared papers, 2017 · strength 0.13
- Yongwei Sun · 1 shared paper, 2021 · strength 0.13
- Xing Liang · 1 shared paper, 2021 · strength 0.13
- Hui Wang · 1 shared paper, 2020 · strength 0.11
- Rong Yue Cao · 1 shared paper, 2020 · strength 0.11
- Hui Wang · 1 shared paper, 2018 · strength 0.10
- Yang Dong · 1 shared paper, 2016 · strength 0.08
- Shuai Huang · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.